Influence of Body Mass Index on Recurrence of Ventricular Arrhythmia, Mortality in Defibrillator Recipients With

Rahul Samanta1, Arun Narayan2, Jim Pouliopoulos1

  • 1Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia.

Insights

Normal body mass index (BMI) in patients with ischaemic heart disease and defibrillators is linked to worse outcomes for ventricular arrhythmias and mortality. Overweight and obese patients showed better survival rates, suggesting an obesity paradox.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Obesity Research

Background:

  • Obesity increases cardiovascular disease risk.
  • The impact of body mass index (BMI) on ventricular arrhythmias (VA) in ischaemic heart disease is not well understood.
  • This study investigates BMI's effect on VA recurrence and mortality in defibrillator recipients with ischaemic cardiomyopathy.

Purpose of the Study:

  • To examine the relationship between body mass index (BMI) and the recurrence of ventricular arrhythmias (VA) and mortality.
  • To assess the influence of BMI on outcomes in patients with ischaemic cardiomyopathy who received defibrillators.

Main Methods:

  • 123 patients with ischaemic cardiomyopathy (left ventricular ejection fraction ≤ 40%) and defibrillators were included.
  • Patients were categorized by BMI: normal (18.5-24.99), overweight (25-29.99), and obese (>30).

Main Results:

  • The combined endpoint of VA recurrence and mortality occurred in 36% of normal BMI, 5.4% of overweight, and 11.5% of obese patients (p=0.001).
  • Normal BMI was a significant predictor of worse outcomes (Hazard Ratio for Normal vs. Overweight = 7.1, p=0.002; Normal vs. Obese = 5.5, p=0.033) after adjusting for risk factors.
  • A trend towards reduced survival was observed in normal BMI patients compared to overweight and obese patients (p=0.08).

Conclusions:

  • Body mass index (BMI) significantly predicts ventricular arrhythmias (VA) and mortality in defibrillator recipients with ischaemic cardiomyopathy.
  • Normal BMI was associated with worse outcomes compared to overweight and obese patients.
  • These findings suggest an obesity paradox in ventricular arrhythmogenesis post-myocardial infarction.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
516
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
803
Reduced Mass Coordinates: Isolated Two-body Problem01:12

Reduced Mass Coordinates: Isolated Two-body Problem

In classical mechanics, the two-body problem is one of the fundamental problems describing the motion of two interacting bodies under gravity or any other central force. When considering the motion of two bodies, one of the most important concepts is the reduced mass coordinates, a quantity that allows the two-body problem to be solved like a single-body problem. In these circumstances, it is assumed that a single body with reduced mass revolves around another body fixed in a position with an...
2.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
459
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
531
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
507